Endocrinology, Vol 127, 1105-1113, Copyright © 1990 by Endocrine Society

ARTICLES

Prostaglandins regulate surfactant protein A (SP-A) gene expression in human fetal lung in vitro

MJ Acarregui, JM Snyder, MD Mitchell and CR Mendelson
Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas 75235-9038.

We previously have observed that dexamethasone has a biphasic effect on surfactant protein A (SP-A) mRNA levels in human fetal lung in vitro. At concentrations of 10(-10)-10(-9) M, dexamethasone increases the levels of SP-A mRNA, whereas, at concentrations greater than 10(-8) M, the steroid is markedly inhibitory. In studies to define the molecular mechanisms for these effects, we observed that dexamethasone causes a dose-dependent stimulation of SP-A gene transcription, but paradoxically causes a dose-dependent inhibition of SP-A mRNA stability. In light of the well-characterized inhibitory effect of glucocorticoids on prostaglandin (PG) synthesis in a number of tissues, it was our objective in the present study to investigate the role of PGs on SP-A gene expression in human fetal lung in vitro and to determine whether the action of dexamethasone (greater than 10(-8) M) to reduce SP-A mRNA levels could be mediated by its effect to inhibit PG synthesis. We found that dexamethasone 10(-7) M) caused a marked decrease in the secreted levels of the PGE2 and PGF2 alpha, the prostacyclin metabolite, 6-keto-PGF1 alpha, and the thromboxane A2 metabolite, thromboxane B2. Indomethacin, which also caused a pronounced reduction in the levels of these secreted prostanoids, had a marked effect to reduce SP-A mRNA levels in human fetal lung in vitro. The inhibitory effects of indomethacin were associated with an 73% reduction in cAMP formation by the fetal lung in culture, and were prevented by simultaneous incubation with dibutyryl cAMP or with PGE2. PGE2 markedly increased cAMP formation by the human fetal lung tissue incubated in the absence or presence of indomethacin. Inhibitory effects of dexamethasone and indomethacin also were observed on two morphological indices of lung differentiation, alveolar lumenal volume density, and lamellar body volume density. PGE2 significantly increased lumenal volume density of the human fetal lung explants. The finding that the inhibitory action of dexamethasone (10(-7) M) on SP-A mRNA levels could not be prevented by simultaneous incubation with either PGE2 or dibutyryl cAMP and that dexamethasone had no apparent effect on cAMP formation by the fetal lung in vitro is suggestive that the action of dexamethasone (greater than or equal to 10(-8) M) to reduce SP-A mRNA levels is mediated at least in part by actions alternative to its inhibitory effects on PG synthesis.(ABSTRACT TRUNCATED AT 400 WORDS)

This article has been cited by other articles:

				K. N. Islam and C. R. Mendelson Glucocorticoid/Glucocorticoid Receptor Inhibition of Surfactant Protein-A (SP-A) Gene Expression in Lung Type II Cells Is Mediated by Repressive Changes in Histone Modification at the SP-A Promoter Mol. Endocrinol., March 1, 2008; 22(3): 585 - 596. [Abstract] [Full Text] [PDF]

				I. Grad, T. A. McKee, S. M. Ludwig, G. W. Hoyle, P. Ruiz, W. Wurst, T. Floss, C. A. Miller III, and D. Picard The Hsp90 Cochaperone p23 Is Essential for Perinatal Survival Mol. Cell. Biol., December 1, 2006; 26(23): 8976 - 8983. [Abstract] [Full Text] [PDF]

				T. S. Sherman, K. L. Chambliss, L. L. Gibson, M. C. Pace, M. E. Mendelsohn, S. L. Pfister, and P. W. Shaul Estrogen Acutely Activates Prostacyclin Synthesis in Ovine Fetal Pulmonary Artery Endothelium Am. J. Respir. Cell Mol. Biol., May 1, 2002; 26(5): 610 - 616. [Abstract] [Full Text] [PDF]

				K. R. KHUBCHANDANI and J. M. SNYDER Surfactant protein A (SP-A): the alveolus and beyond FASEB J, January 1, 2001; 15(1): 59 - 69. [Abstract] [Full Text] [PDF]

				J. L. Alcorn, R. E. Hammer, K. R. Graves, M. E. Smith, S. D. Maika, L. F. Michael, E. Gao, Y. Wang, and C. R. Mendelson Analysis of genomic regions involved in regulation of the rabbit surfactant protein A gene in transgenic mice Am J Physiol Lung Cell Mol Physiol, August 1, 1999; 277(2): L349 - L361. [Abstract] [Full Text] [PDF]

				M. J. Acarregui, S. T. Penisten, K. L. Goss, K. Ramirez, and J. M. Snyder Vascular Endothelial Growth Factor Gene Expression in Human Fetal Lung In Vitro Am. J. Respir. Cell Mol. Biol., January 1, 1999; 20(1): 14 - 23. [Abstract] [Full Text]

				P. W. Shaul, M. C. Pace, Z. Chen, and T. S. Brannon Developmental Changes in Prostacyclin Synthesis Are Conserved in Cultured Pulmonary Endothelium and Vascular Smooth Muscle Am. J. Respir. Cell Mol. Biol., January 1, 1999; 20(1): 113 - 121. [Abstract] [Full Text]

				T. S. Brannon, A. N. MacRitchie, M. A. Jaramillo, T. S. Sherman, I. S. Yuhanna, L. R. Margraf, and P. W. Shaul Ontogeny of cyclooxygenase-1 and cyclooxygenase-2 gene expression in ovine lung Am J Physiol Lung Cell Mol Physiol, January 1, 1998; 274(1): L66 - L71. [Abstract] [Full Text] [PDF]

				J. L. Alcorn, M. E. Smith, J. F. Smith, L. R. Margraf, and C. R. Mendelson Primary Cell Culture of Human Type II Pneumonocytes: Maintenance of a Differentiated Phenotype and Transfection with Recombinant Adenoviruses Am. J. Respir. Cell Mol. Biol., December 1, 1997; 17(6): 672 - 682. [Abstract] [Full Text]

				L. F. Michael, M. A. Lazar, and C. R. Mendelson Peroxisome Proliferator-Activated Receptor {gamma}1 Expression Is Induced during Cyclic Adenosine Monophosphate-Stimulated Differentiation of Alveolar Type II Pneumonocytes Endocrinology, September 1, 1997; 138(9): 3695 - 3703. [Abstract] [Full Text] [PDF]

				M. Yi, G.-X. Tong, B. Murry, and C. R. Mendelson Role of CBP/p300 and SRC-1 in Transcriptional Regulation of the Pulmonary Surfactant Protein-A (SP-A) Gene by Thyroid Transcription Factor-1 (TTF-1) J. Biol. Chem., January 18, 2002; 277(4): 2997 - 3005. [Abstract] [Full Text] [PDF]